Michael Handelman
2014 - Lion Biotechnologies
In 2014, Michael Handelman earned a total compensation of $1.8M as Chief Financial Officer at Lion Biotechnologies, a 874% increase compared to previous year.
Compensation breakdown
| Bonus | $45,000 |
|---|---|
| Option Awards | $887,507 |
| Salary | $180,000 |
| Stock Awards | $641,250 |
| Total | $1,753,757 |
Handelman received $887.5K in option awards, accounting for 51% of the total pay in 2014.
Handelman also received $45K in bonus, $180K in salary and $641.3K in stock awards.
Rankings
In 2014, Michael Handelman's compensation ranked 5,069th out of 13,032 executives tracked by ExecPay. In other words, Handelman earned more than 61.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,069 out of 13,032 | 61st |
Division Manufacturing | 1,806 out of 4,965 | 64th |
Major group Chemicals And Allied Products | 597 out of 1,690 | 65th |
Industry group Drugs | 455 out of 1,369 | 67th |
Industry Biological Products, Except Diagnostic Substances | 76 out of 241 | 69th |
Source: SEC filing on April 30, 2015.
Handelman's colleagues
We found four more compensation records of executives who worked with Michael Handelman at Lion Biotechnologies in 2014.